4893 items matching your search terms.

Risk of recurrence, subsequent mode of birth and morbidity for women who experienced severe perineal trauma in a first birth in New South Wales between 2000—2008: a population based data linkage study

Priddis, H. Dahlen, H.G. Schmied, V. Sneddon, A. Kettle, C. Brown, C. Thornton, C.
BMC PREGNANCY AND CHILDBIRTH, 2013     DOI:10.1186/1471-2393-13-89

Fenofibrate rescues diabetes-related impairment of ischaemia-mediated neovascularisation

Rajamani, K Yuan, J Lecce, L Jenkins, A Keech, A Ng, M
, 2013     DOI:10.1016/j.hlc.2013.05.035

Psychosocial issues of women with type 1 diabetes transitioning to motherhood: a structured literature review

Rasmussen, B.B. Hendrieckx, C. Clarke, B. Botti, M. Dunning, T. Jenkins, A. Speight, J.
BMC PREGNANCY AND CHILDBIRTH, 2013     DOI:10.1186/1471-2393-13-218

Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: design of the TEXT and SOFT trials

Regan, M.M. Pagani, O. Fleming, G.F. Walley, B.A. Price, K.N. Rabaglio, M. Maibach, R. Ruepp, B. Coates, A.S. Goldhirsch, A. Colleoni, M. Gelber, R.D. Francis, P.A.

A phase I/II study of the vascular disrupting agent BNC105P in combination with gemcitabine-carboplatin in partially platinum-sensitive ovarian cancer patients in first or second relapse: An international collaborative group trial of ANZGOG and HOG

Rischin, D Matei, D Goh, JC Vaughan, MM Beale, PJ Tenney, ME Martyn, J Sommeijer, DW Iglesias, JL Bibby, DC Simpson, J Doolin, EE Williams, CE Stockler, MR

Parents’ attitudes to aspects of perinatal trials. An online survey via social media

Rohr, N Cruz, M Tarnow-Mordi, WO

Risk of treatment-related mortality with bevacizumab treatment in advanced cancers

Roncolato, F Ding, P Lord, SJ Gebski, V Lee, CK

Immune cell-mediated inflammation and the early improvements in glucose metabolism after gastric banding surgery

Samaras, K. Viardot, A. Botelho, N.K. Jenkins, A. Lord, R.V.N.
DIABETOLOGIA, 2013     DOI:10.1007/s00125-013-3033-7

Commercial, societal and administrative benefits from the analysis and clarification of definitions: the case of nanomaterials

Saner, M. Stoklosa, A.
CREATIVITY AND INNOVATION MANAGEMENT, 2013     DOI:10.1111/caim.12014

Inter-generational effects of nutrient status and increased susceptibility to diabetes in a “thrifty jerry”

Satoor, SN Karandikar, MS Patil, DP Puranik, AS Joglekar, MV Kristensen, HD Umrani, M Bhat, DS Yajnik, CS Kumar, S Bhonde, RR Hardikar, AA

A 'Thrifty Jerry': a rat model of multigenerational undernutrition, insulin resistance and visceral adiposity

Satoor, SN Karandikar, MS Puranik, AS Joglekar, MV Ranjan, AK Dalvi, MP Limaye, A Kumar, S Umrani, MR Bhat, DS Bhonde, RR Yajnik, CS Galande, S Hardikar, AA

Human gallbladder epithelial cells for treatment of diabetes

Satoor, SN Williams, M Hetherington, N Yang,SN Loudovaris, T Jhala, G Martin, D Thiruchelvam, D Reddy, DN Rao, GV Mitnala, S Stanley, E Elefanty, A Thomas, HE Kay, TW Tosh, D Hardikar, AA

Maternal nutrition, nutrient transfer & foetal pancreas development

Satoor, S.N. Hardikar, A.A.

Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: first results of the PETACC-6 randomized phase III trial

Schmoll, HJ Haustermans, K Price, TJ Nordlinger, B Hofheinz, R Daisne, JF Janssens, J Brenner, B Schmidt, P Reinel, H Hollerbach, S Caca, K Fauth, FWB Hannig, C Zalcberg, JR Tebbutt, NC Mauer, ME Messina, CGM Lutz, MP Van Cutsem, E for the EORTC GITCG, AIO, AGITG, EORTC ROG, BGDO, FFCD,

Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer: response to the local treatment after chemoradiation and surgery as secondary endpoint

Schmoll, HJ Price, T Haustermanns, K Nordlinger, B Hofheinz, RD Daisne, JF Janssens, J Schmidt, P Reinel, H van Cutsem, E EORTC GITCG, AIO, AGITG, EORTC ROG, BGDO, FFCD,
, 2013     DOI:10.1159/000356365